These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18372275)

  • 1. Antigenic (immunogenic) profiling of bovine thrombin and its purified forms.
    Walenga JM; Bick RL; Messmore HL
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):133-4. PubMed ID: 18372275
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced immunogenic potential of membrane filtered bovine thrombin preparations for hemostatic application.
    Zhu H; Hoppensteadt D; Wahi R; Cunanan J; Adiguzel C; Bick RL; Fareed J
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):32-40. PubMed ID: 18977777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative purity of different bovine thrombin preparations.
    Zhu H; Hoppensteadt D; Iqbal O; Litinas E; Adiguzel C; Fareed J
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):681-8. PubMed ID: 19850589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of immunogenic potentials of bovine thrombin preparations.
    Zhu H; Hoppensteadt D; Adiguzel C; Bick RL; Fareed J
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):41-9. PubMed ID: 19117966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific activities of bovine thrombin and thrombin components.
    Waugh DF; Rosenberg RD
    Thromb Diath Haemorrh; 1972 Apr; 27(2):183-95. PubMed ID: 5049608
    [No Abstract]   [Full Text] [Related]  

  • 6. A study on the properties of commercial thrombin preparations.
    Suzuki S; Sakuragawa N
    Thromb Res; 1989 Feb; 53(3):271-7. PubMed ID: 2655160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further removal of factor v related antigen from bovine thrombin by utilizing a membrane-filtration step.
    Terrab A; Pawlak D; Spaay P; Hoppensteadt D; Fareed J
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):135-40. PubMed ID: 18160573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human and bovine plasminogen-free thrombin, purified by means of gel filtration and ion exchange chromatography.
    Berg W; Korsan-Bengtsen K; Ygge J
    Thromb Diath Haemorrh; 1966 May; 15(3):501-10. PubMed ID: 5989033
    [No Abstract]   [Full Text] [Related]  

  • 9. Bovine thrombin and the clinical consequence of antibody development.
    Cronstein BN
    J Am Coll Surg; 2008 Jan; 206(1):199; author reply 199-200. PubMed ID: 18155591
    [No Abstract]   [Full Text] [Related]  

  • 10. Preparation and partial characterization of two forms of bovine thrombin.
    Lundblad RL; Uhteg LC; Vogel CN; Kingdon HS; Mann KG
    Biochem Biophys Res Commun; 1975 Sep; 66(2):482-9. PubMed ID: 1237299
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-D contaminating human thrombin].
    Martín Vega C; Piqueras J; Pérez Anoro P; Durán-Suárez JR
    Sangre (Barc); 1986; 31(4):507. PubMed ID: 3024338
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological consequences of topical bovine thrombin.
    Zehnder JL; Leung LL
    Am J Pathol; 2001 Dec; 159(6):2371. PubMed ID: 11733385
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of thrombin activity in pharmaceutical forms by RP-HPLC.
    Scalia S; Ascenzi P; Bortolotti F; Guarneri M; Menegatti E
    Pharm Acta Helv; 1988; 63(8):224-6. PubMed ID: 3231655
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent developments in topical thrombins.
    Kessler CM; Ortel TL
    Thromb Haemost; 2009 Jul; 102(1):15-24. PubMed ID: 19572062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-mediated coagulopathy: a case report.
    Naoum JJ
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):13S-7S. PubMed ID: 19558280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the apparent thrombogenicity of thrombin.
    Yin ET; Wessler S
    Thromb Diath Haemorrh; 1968 Dec; 20(3):465-8. PubMed ID: 5751636
    [No Abstract]   [Full Text] [Related]  

  • 17. Exogenous bovine thrombin as a biomarker of exposure and outcome.
    Crean SM; Michels SL; Reynolds MW
    Expert Rev Mol Diagn; 2008 Sep; 8(5):651-61. PubMed ID: 18785812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of a DNA aptamer-Pt complex and its use in the colorimetric sensing of thrombin and anti-thrombin antibodies.
    Higuchi A; Siao YD; Yang ST; Hsieh PV; Fukushima H; Chang Y; Ruaan RC; Chen WY
    Anal Chem; 2008 Sep; 80(17):6580-6. PubMed ID: 18665606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneously fluorescence detecting thrombin and lysozyme based on magnetic nanoparticle condensation.
    Wang L; Li L; Xu Y; Cheng G; He P; Fang Y
    Talanta; 2009 Aug; 79(3):557-61. PubMed ID: 19576412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrochemical detection of thrombin by sandwich approach using antibody and aptamer.
    Kang Y; Feng KJ; Chen JW; Jiang JH; Shen GL; Yu RQ
    Bioelectrochemistry; 2008 Jun; 73(1):76-81. PubMed ID: 18539098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.